The localized prostate cancer treatment study published in the New England Journal of Medicine in April 2023, conducted in the United Kingdom from 1999 to 2009, aimed to assess the effectiveness of active monitoring, prostatectomy, and radiotherapy in reducing prostate cancer-specific mortality.
The study included three groups, and after 15 years of follow-up, it was found that the prostate cancer-specific mortality was low, regardless of the treatment assigned.
The findings of this study suggest that the choice of therapy for localized prostate cancer should be based on its risks, benefits, and side effects, including the long-term side effects. While the study published provides valuable insights into the effectiveness of different treatments for localized prostate cancer, it is important to consider the limitations of the study when interpreting the results.
The decision to choose a treatment option for localized prostate cancer should be based on a thorough consideration of the individual patient’s medical history, values, and preferences.
